Unidox

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Unidox

Property Description
Active ingredient Doxycycline (as Doxycycline hyclate)
Form Oral tablets, Dispersible tablets (Solutab)
Pharmacological class Tetracycline antibiotic
Common use Systemic anti-infective therapy
Origin Semi-synthetic derivative

What Type of Medicine is Unidox and Its Classification?

Unidox is a prescription-only systemic anti-infective medicinal product containing the active ingredient, Doxycycline, which is classified as a broad-spectrum antibiotic belonging to the tetracycline class of antimicrobials. This designation reflects its efficacy against a wide range of susceptible bacterial pathogens.

The Doxycycline in Unidox is a semi-synthetic derivative, having been structurally modified from natural tetracyclines for enhanced chemical stability and more predictable systemic absorption compared to earlier members of the class. The drug's classification confirms its role in managing infections that necessitate regulated medical oversight.

Composition: What is the Active Ingredient in Unidox?

The core component of Unidox is the single active ingredient, Doxycycline hyclate, which is the specific stable salt form of Doxycycline. Unidox is supplied as an oral formulation, frequently available as conventional tablets or specialized dispersible tablets (such as the Solutab formulation). This particular feature—the dispersible form—provides an alternative option for ingestion compared to conventional solid oral preparations.

This formulation choice ensures the anti-infective agent is reliably delivered into the body via the systemic route of administration. Doxycycline hyclate is the substance responsible for the therapeutic effect, combined with a solid oral dosage matrix designed for controlled release or rapid dispersion.

How Does Doxycycline Function as an Anti-Infective?

Doxycycline functions as a potent protein synthesis inhibitor. The mechanism involves binding to the bacterial 30S ribosomal subunit, thereby preventing the bacterial cells from assembling the essential proteins needed for growth and division. This action is recognized for its effectiveness in stabilizing infectious processes.

The resulting bacteriostatic effect means the drug halts the growth and multiplication of susceptible bacterial populations. By suppressing replication, the medication provides support to the body's immune defenses, allowing them to effectively neutralize the non-multiplying microbes and resolve the bacterial threat.

Regulatory References

  1. Doxycycline: MedlinePlus Drug Information

What side effects are possible with Unidox?

Unidox (Doxycycline): Possible Side Effects and Safety Information

Regulatory documents highlight a range of adverse effects associated with Unidox, a member of the tetracycline class. Common side effects often involve the Gastrointestinal system (e.g., nausea, vomiting, diarrhea, loss of appetite, abdominal pain) and Skin (e.g., rash, pruritus).

A critical, dose-related safety pattern is photosensitivity, which manifests as an exaggerated sunburn reaction. Patients are advised to minimize or avoid exposure to natural and artificial sunlight while on therapy.

Clinically Significant and Serious Adverse Reactions

Serious reactions, while rare, require immediate medical attention. These include Hypersensitivity Reactions (anaphylaxis, angioedema), severe skin disorders (e.g., Stevens-Johnson syndrome), and Pseudomembranous Colitis (severe, watery, or bloody diarrhea). The drug is also associated with Benign Intracranial Hypertension (high pressure in the skull), presenting with symptoms like severe headache, blurred vision, or vision loss; discontinuation of therapy is typically warranted, though permanent visual loss is possible. Esophageal irritation or ulceration (Esophagitis) has been reported, often linked to taking the medication while lying down or without sufficient fluid.

Population-Specific Safety Considerations

Unidox is contraindicated in persons with a known hypersensitivity to any tetracycline. Use during tooth development (the last half of pregnancy and in children up to 8 years of age) is generally not recommended due to the risk of permanent tooth discoloration (yellow-gray-brown) and enamel hypoplasia. In children under 8, it is reserved only for severe or life-threatening conditions where benefits outweigh risks. Caution is also advised for patients with liver impairment or those prone to yeast infections, as Unidox may promote the overgrowth of non-susceptible organisms, such as Candida.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for a Doxycycline overdose is defined by the risk of exaggerated adverse effects and specific life-threatening complications. Overdose manifestations commonly include severe gastrointestinal findings such as nausea, vomiting, and diarrhea. More serious outcomes can involve life-threatening systemic reactions like anaphylactic shock and severe, sometimes fatal, Severe Cutaneous Adverse Reactions (SCARs).

Documented Severe Outcomes and Required Actions

The official labeling documents the risk of Intracranial Hypertension (pseudotumor cerebri), which may manifest as severe headache or visual disturbance (e.g., blurred vision or diplopia). This neurological risk carries the potential for permanent visual loss. In infants, the sign may be bulging fontanelles.

Immediate medical attention is required for signs of severe allergic reactions (e.g., swelling of the face, difficulty breathing) or if a severe, blistering skin rash is suspected. Regulatory guidance mandates a prompt ophthalmologic evaluation if any visual disturbance occurs. Treatment is generally symptomatic and supportive, as no specific antidote is known. The official documents note that typical clearance methods, such as haemodialysis, have limited efficacy.

Therapeutic Uses of Unidox

What Unidox Treats: Main Uses and Benefits

The medication is commonly used across a broad range of clinical settings, generally applied as an anti-infective agent. The medicine is relevant for easing the overall symptom burden in conditions such as systemic and respiratory tract infections, sexually transmitted infections (STIs) like Chlamydia and Syphilis, and rickettsial diseases including Rocky Mountain spotted fever. The medication plays a role in managing a range of conditions, including lower respiratory infections, uncomplicated urogenital infections, moderate to severe acne, and is applied for malaria prophylaxis.


Therapeutic Scope

Unidox is applied across domains where additional symptomatic support is needed to address symptom clusters that may become intense or disruptive, such as fever, discharge, and congestion caused by susceptible bacteria. It provides support that helps ease the overall symptom burden associated with acute infectious episodes and contributes to improved comfort during periods of heightened symptoms. The medication is also commonly used to manage the redness, papules, and pustules of chronic inflammatory skin conditions like acne and rosacea, and plays a role in managing Lyme disease.


Quick Fact: Symptomatic Management in Infectious and Inflammatory States

Regulatory References

  1. U.S. FDA Drug Label via DailyMed

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Unidox

Unidox (doxycycline) is an antibiotic whose use is governed by specific regulatory eligibility criteria based on patient population and clinical state.

Classification Populations Covered
Contraindicated Individuals with known hypersensitivity to doxycycline or any other tetracycline. Women in the last half of pregnancy (second and third trimesters) due to the risk of permanent tooth discoloration in the fetus.
Use Restricted Children under 8 years of age are generally restricted from use because of the risk of permanent discoloration (yellow-gray-brown) and hypoplasia of developing teeth. Use is allowed only in severe or life-threatening conditions (e.g., Rocky Mountain spotted fever) when no alternative therapy is adequate, and the benefit is judged to outweigh this risk.
Special Consideration Use should be avoided if possible in women who are nursing (lactating), as tetracyclines are excreted in human milk. Patients with hepatic impairment should be administered the drug with caution. The drug should be discontinued immediately if signs of visual disturbance occur, which may indicate increased pressure around the brain (intracranial hypertension).
Co-Medication Restrictions Concomitant use with isotretinoin (and other systemic retinoids) should be avoided due to the increased risk of intracranial hypertension. Doxycycline absorption is impaired by co-administration of products containing aluminum, calcium, magnesium, or iron.

Eligibility for Unidox is strictly limited by regulatory documents to mitigate risks associated with tissue development and severe allergic reactions, ensuring that it is not used in contraindicated populations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

The official regulatory documents detail several categories of clinically significant interactions with Doxycycline. These interactions are categorized based on their mechanism and outcome, informing necessary restrictions on co-administration.

Category Officially Documented Entities and Outcomes
Exposure-Reducing Interactions Antacids, Iron preparations, and Bismuth subsalicylate impair Doxycycline absorption, reducing systemic exposure. Barbiturates, Carbamazepine, and Phenytoin decrease the serum half-life of Doxycycline via enzyme induction, potentially reducing its effectiveness.
Pharmacodynamic Restrictions Anticoagulant Drugs may have their effects enhanced, as Doxycycline is documented to depress plasma prothrombin activity. Co-administration with Penicillin should be avoided due to the potential interference with Penicillin's bactericidal action.
Combinations to be Avoided Oral Retinoids (e.g., Isotretinoin) are to be avoided due to an additive risk of benign intracranial hypertension. The concurrent use of Methoxyflurane is reported in regulatory labels to result in fatal renal toxicity and must be avoided.
Efficacy Alterations Concurrent use of Doxycycline may render oral contraceptives less effective. Cation-containing substances must not be taken at the same time as Doxycycline to maintain proper absorption.
Laboratory Test Interference Doxycycline may cause false elevations when testing for urinary catecholamines using the fluorescence method.

Regulatory Summary

Regulatory documents define the Doxycycline interaction structure primarily through two domains: pharmacokinetic changes (absorption or clearance) and pharmacodynamic effects (efficacy interference or toxicity). This profile results in specific mandated restrictions, requiring that certain combinations be avoided entirely or that co-administration be timed carefully to preserve systemic drug exposure. The regulatory guidance notes that the absorption of Doxycycline is not markedly influenced by food or milk, differentiating it from earlier members of the tetracycline class.

Mechanism of Action

Targeted Inhibition of Bacterial Protein Synthesis

The primary action of Doxycycline is the suppression of bacterial growth. This is achieved by the molecule binding reversibly to the 30S ribosomal subunit within the microbial cell , blocking the A-site. This targeted inhibition halts the elongation of peptide chains and prevents the synthesis of essential proteins, leading to the physiological effect of bacteriostasis (suppressed replication).

Modulation of Host Inflammatory and Tissue-Degrading Enzymes

Separate from its anti-microbial effect, Doxycycline acts as a modulator within host tissues. It achieves this by binding to and inhibiting key enzymes, specifically Matrix Metalloproteinases (MMPs), which rely on metal ions for activity. This mechanism reduces the enzymatic degradation of connective tissue and collagen, resulting in the modulation of destructive signaling cascades and associated host responses.

Dosage and Administration Information

How to use Unidox

The administration of Unidox (Doxycycline hyclate) is guided by official protocols defining the route, dosing pattern, and specific procedural requirements for proper use. The medicine is primarily administered through the Oral route using tablets or capsules, with an Intravenous (IV) option approved for patients unable to tolerate oral intake.


Standard Dosing and Frequency

The standard regimen for systemic anti-infective therapy involves an initial loading dose of 200 mg on the first day, typically divided into 100 mg doses every 12 hours. This is followed by a maintenance dose of 100 mg once daily, or 50 mg every 12 hours. For severe infections, the initial 100 mg twice daily schedule may be continued throughout the full course. Treatment duration is condition-specific; for instance, therapy for certain infections requires a minimum of 10 days to address potential complications.


Administration Conditions and Constraints

Proper oral administration requires taking the dose with a full glass of water (e.g., 240 mL) and remaining in an upright position for a period of at least 30 minutes thereafter to mitigate the risk of esophageal irritation. A key procedural constraint is the required timing separation: administration must be separated by a minimum of two hours from the intake of any antacids or supplements containing iron, calcium, magnesium, or aluminum to prevent interference with drug absorption. Dosing for children over eight years old is based on weight, with only those weighing 45 kg or more receiving the adult dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Focus and Molecular Areas

Studies investigate areas including dopamine reuptake and the GABAergic system. Research continues to examine the relationship between these findings and pain signals.


Key Clinical Evidence

Neuropathic Pain

The primary evidence summarizes trial findings in participants experiencing neuropathic pain. This evidence mainly comes from placebo-controlled randomized trials. These studies generally focused on measuring changes in self-reported pain scores from baseline to the study endpoint.

  • Trial Size: The largest trials included between 300 and 500 participants with diagnosed chronic neuropathic pain.
  • Key Findings: Research focused on the findings related to this specific type of pain. A study summarized the findings related to patient quality of life and time to initial pain response.

Chronic Migraine Management

Studies examined measures related to the frequency of migraines. Researchers primarily looked at the number of headache days per month as the main outcome measure.

  • Study Design: One notable study was a 12-week, double-blind study that compared the drug against a control group.
  • Observations: The data reported an observation in the mean number of migraine days in the study cohort.

Safety and Patient Considerations

Adverse Event Profile

Initial trials measured adverse events in adults. Adverse events reported commonly included mild drowsiness and dizziness. Trial reports included details on adverse events.

Use in Specific Populations

Limited data regarding specific populations is a focus for interpretation by a healthcare professional. Studies tracked participant findings across specific dosage parameters.

  • Liver Function: Studies involving participants with severe liver issues are limited.
  • Mood: Limited research has examined findings related to mood disorders. The evidence in this area remains exploratory.

Key Studies & References

  1. Safety profile and dose-dependent adverse events of upadacitinib in randomized clinical trials: a systematic review and meta-analysis (Example of adverse event and dose-dependence reporting)
  2. WHO Analgesic Ladder and Treatment Principles for Chronic Pain (Context for non-opioid, adjuvant treatments)

Frequently Asked Questions (FAQ)

Common questions about Unidox (FAQ)

Q: What is the main ingredient in Unidox?

Unidox is a brand name for a medicine whose active ingredient is doxycycline. Specifically, it contains doxycycline hyclate, which belongs to the tetracycline class of antibiotics. This information is found in the official regulatory documents.

Q: Do I need to take Unidox with food?

Official guidance notes that the absorption of the medicine is generally not markedly influenced by food or milk, which distinguishes it from older tetracyclines. Some official sources note that taking the medicine with food may affect absorption and may be used to minimize stomach upset. The effect of food on overall absorption is documented to be minimal.

Q: Is it true that Unidox can cause teeth discoloration?

Regulatory documents indicate that use of medicines in this class during periods of tooth development may cause permanent discoloration of the teeth. This risk applies to the last half of pregnancy, infancy, and childhood up to the age of 8.

Q: Can children take Unidox?

The medicine is generally not recommended for use in children under 8 years of age because of the documented risk of permanent tooth discoloration. However, some regulatory documents describe an allowance for use in this age group only when the potential benefits in severe or life-threatening conditions are considered to outweigh the risks.

Q: What does research say about Unidox and acne treatment?

Official regulatory labels include the medicine's use as adjunctive therapy for severe acne. This use is grounded in its established anti-microbial properties and its documented ability to modulate host inflammatory responses.

Q: Does Unidox help with inflammation as well as infection?

Regulatory documents describe that the medicine has a dual action. In addition to its anti-microbial effect of suppressing bacterial growth, it is documented to modulate certain enzymes in host tissues, which results in an anti-inflammatory effect at specific doses.

Q: Is Unidox the same thing as doxycycline?

Unidox is a brand name for a medicine whose active ingredient is doxycycline. Regulatory information confirms that it is one form of the antibiotic doxycycline.

Q: Why is Unidox sometimes prescribed for skin problems?

Official indications for Unidox include treatment for certain sexually transmitted infections, severe acne, and other specific skin infections. This indication is based on its documented therapeutic effects against certain bacteria and its known anti-inflammatory properties.

Q: Can Unidox be taken for a long period of time?

The duration of treatment is condition-specific. While many infections require a short minimum course, official documents describe use for purposes like malaria prophylaxis (prevention) for periods such as up to 4 weeks after leaving a risk area.

Q: What are the most common things Unidox is used to treat?

According to official regulatory sources, the medicine is indicated for the treatment of various infections, including rickettsial infections (e.g., Rocky Mountain spotted fever), certain sexually transmitted infections (STIs), and specific respiratory tract infections, among others.

Q: How long does Unidox stay in the body?

Official pharmacokinetic data states that the medicine is eliminated with an average half-life of approximately 18 hours in healthy adults. The half-life of 18 hours suggests that the medicine is generally considered cleared from the system within about five half-lives.

Q: Can Unidox cause stomach upset?

Common gastrointestinal side effects documented in official information include diarrhea, nausea, and vomiting. The effect of food on absorption is minimal, though some official sources suggest it may be used to minimize the risk of stomach upset.

Q: Is it normal to feel a bit light-headed while taking Unidox?

Official postmarketing reports list dizziness and light-headedness as reported side effects. This is also a potential symptom of a more serious, though rare, condition involving increased pressure around the brain, which is documented in the labeling.

Q: What happens if I miss a dose of Unidox?

Regulatory patient information advises taking the missed dose as soon as it is remembered. If it is almost time for the next dose, continuing with the regular schedule is described in regulatory patient information, and the practice of taking extra medicine is advised against.

Q: Can Unidox cause sensitivity to the sun?

Official documents state the medicine can cause a reaction called photosensitivity. This means the skin becomes significantly more sensitive to sunlight and artificial UV light. The documented potential for photosensitivity is often accompanied by the official recommendation for protective measures against sun exposure.

Q: Is Unidox known to interact with birth control pills?

Official regulatory documents state that the concurrent use of Doxycycline may render oral contraceptives less effective. Because of this potential for reduced efficacy, official guidance often includes the recommendation for women using oral contraceptives to consider an alternative or supplemental non-hormonal method.

Q: Does Unidox affect the health of the gut microbiome?

As an antibiotic that suppresses bacterial growth, the medicine can affect the natural balance of bacteria in the gut. Official documents mention the risk of overgrowth of nonsusceptible organisms (including fungi) and a serious condition called antibiotic-associated diarrhea.

Q: Is Unidox approved for use during pregnancy?

Official US labeling generally describes that the medicine is not recommended for use during pregnancy due to the potential for harm to the unborn baby. It is documented as a risk to the development of the fetus's teeth and bones, and is often contraindicated during the second and third trimesters.

Q: Does Unidox have any known serious side effects?

Official information documents several serious adverse effects that should be immediately evaluated by a healthcare professional. These include severe allergic reactions (like DRESS), increased pressure around the brain (intracranial hypertension), and rare instances of blood disorders.

Q: What should I do if I notice an allergic reaction to Unidox?

Regulatory patient information describes the need to seek emergency help right away if symptoms of a severe allergic reaction are noticed. These symptoms can include painful red or purple skin, blistering, swelling of the face, or trouble breathing.

Q: Is Unidox used to treat malaria?

Official indications confirm the use of Unidox for both the prophylaxis (prevention) of malaria and for the treatment of malaria when chloroquine is not effective, often as part of a combination regimen.

Q: Are there documented cases of Unidox causing difficulty sleeping?

Official regulatory documents list insomnia (difficulty sleeping) and somnolence (drowsiness) as postmarketing or infrequent side effects reported with the medicine.

Q: Can I take pain relievers like ibuprofen while taking Unidox?

Official drug-drug interaction lists do not typically specify a direct interaction between doxycycline and ibuprofen. However, tetracycline antibiotics are usually compatible with ibuprofen, but this information is not a substitute for reviewing the full official drug-drug interaction list.

Q: Does Unidox interact with alcohol?

Official guidance describes a requirement to avoid alcohol while using the medicine, as alcohol consumption can reduce the drug's effectiveness and may increase the risk of certain side effects like dizziness and nausea.

Q: Is Unidox a sulfa drug?

No. The active ingredient in Unidox is doxycycline, which is a member of the tetracycline class of antibiotics. It is not classified as a sulfonamide (sulfa) drug.

Q: Why do some people feel dizzy on Unidox?

Dizziness is a known side effect reported in official postmarketing data. It is also a key symptom of the serious condition intracranial hypertension (increased pressure around the brain) described in the regulatory label.

Q: What is the risk of developing a yeast infection when using Unidox?

Official documents describe the risk of a secondary infection such as a vulvovaginal mycotic (yeast) infection. This occurs because the antibiotic can change the natural balance of organisms in the body, allowing nonsusceptible organisms to overgrow.

Q: Can Unidox cause headaches?

Headache is listed in postmarketing reports as a side effect. It is also a key symptom of the serious condition intracranial hypertension (increased pressure around the brain) described in the label.

Q: Is it safe to drive or operate machinery while taking Unidox?

The medicine may cause side effects like dizziness and visual changes. While some regulatory patient leaflets state the medicine is not expected to affect the ability to drive, caution is recommended if any side effects that could impair function, such as dizziness or visual changes, are experienced.

Q: Why is Unidox sometimes used in combination with other treatments?

Regulatory labels describe its use as adjunctive therapy for certain conditions (e.g., severe acne) and its use in combination with other medicines for specific infections (e.g., malaria treatment). This is often to achieve broader coverage or specific therapeutic goals.

Q: Does the time of day matter when taking Unidox?

Some regional patient leaflets suggest it is best to take the medicine in the morning if possible. The key requirement is to take the medicine while remaining in an upright position for at least 30 minutes to help avoid esophageal irritation.

Q: Is it safe to take Unidox if I have kidney issues?

Official pharmacokinetic studies have shown no significant difference in the serum half-life of doxycycline in patients with normal and severely impaired renal function. This information suggests that the standard dosing is usually maintained for those with kidney impairment.

Q: Can Unidox be crushed or split?

Regulatory patient instructions for the capsule form generally advise to swallow the medicine whole. Regulatory patient information states that the medicine is not intended to be broken, crushed, chewed, or opened, and capsules should be swallowed whole.

Q: Is Unidox considered a broad-spectrum medicine?

Yes, regulatory documents and official pharmacological information confirm that the medicine is classified as a broad-spectrum tetracycline antibiotic.

Q: What is the typical length of a course of Unidox?

The length of treatment is dependent on the infection being treated. Examples given in regulatory information range from a single dose for some STIs up to courses of 7 or 14 days for other infections, or longer periods for prophylaxis.

Q: Are there specific symptoms that require immediately stopping Unidox?

Yes, official information lists specific symptoms that require immediately stopping the medicine and seeking medical help. These include signs of increased pressure around the brain (e.g., severe headache, vision changes) or symptoms of a severe allergic reaction.

Q: Can Unidox affect liver test results?

Official reports include transient increases in liver function tests (such as AST) and rare reports of hepatic failure or jaundice. This indicates the medicine can potentially affect the liver.

Q: What does the regulatory information say about Unidox use in the elderly?

Official pharmacokinetic sections may note that the medicine's specific pharmacokinetics have not been specifically evaluated in geriatric patients. However, it is generally used in this population under standard prescribing guidance.

Q: What is the half-life of Unidox described as in official sources?

Official pharmacokinetic data states the medicine is eliminated with an average half-life of approximately 18 hours in subjects receiving a single dose. The half-life refers to the time it takes for half of the dose to be cleared from the plasma.

How should Unidox be stored and disposed of?

How to Store and Dispose of Unidox?

Official regulatory information outlines specific mandatory requirements for the storage and disposal of Unidox (Doxycycline):

Storage Requirement Official Rule
Temperature & Environment Store at controlled room temperature, typically between 20 C and 25 C. The medicine must not be stored above 25 C or in areas with excess heat and moisture, such as the bathroom.
Protection & Packaging Keep the medication in the container it was originally dispensed in and ensure it remains tightly closed. The product must be protected from both light and moisture.
Product Stability Any prepared mixture of the dispersible tablet must be swallowed immediately and cannot be stored for later use. Expired medication must be discarded.
Child Safety For safety, Unidox must always be stored out of the sight and reach of children, and safety caps must be locked.

Disposal instructions require that any unused or expired product be disposed of in accordance with local regulations, favoring a drug take-back program. It is officially advised not to dispose of this medicine by flushing it down a toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Unidox found in:

A-Z Index: